Stock listing

SLP Stock Price, News, Filings & Events — Simulations Plus, Inc.

Selected listing: SLP · BOATS · USD · US

This page tracks Simulations Plus, Inc.'s SLP:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SLP:BOATS. SLP:BOATS is the stock-level entry point for investors researching Simulations Plus, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Simulations Plus, Inc. (Ticker: SLP) is a public company based in the United States, specializing in software and services for drug discovery and development. With a market capitalization of approximately $368.7 million, the company focuses on providing innovative solutions to enhance the efficiency of pharmaceutical research.

SLP:BOATSUSDUSUpdated September 18, 2026
Simulations Plus, Inc. logo
Ticker
SLP:BOATS
Asset type
Stock
Market cap
$372.9M
Sector
Technology Services
Industry
Packaged Software
Exchange
BOATS
Currency
USD

Simulations Plus, Inc. SLP:BOATS stock context

This page tracks Simulations Plus, Inc.'s SLP:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SLP:BOATS. SLP:BOATS is the stock-level entry point for investors researching Simulations Plus, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Simulations Plus, Inc. (Ticker: SLP) is a public company based in the United States, specializing in software and services for drug discovery and development. With a market capitalization of approximately $368.7 million, the company focuses on providing innovative solutions to enhance the efficiency of pharmaceutical research.

Latest news from Simulations Plus, Inc.

All Simulations Plus, Inc. news →

Simulations Plus, Inc. earnings calls

Research Simulations Plus, Inc.

Alternate listings